NCT03174613View on ClinicalTrials.gov

A Study To Evaluate The Safety, Pharmacokinetics/Pharmacodynamics (PK/PD) and Food Effect Of LC51-0255

PHASE1CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 31, 2017

Primary Completion Date

June 12, 2019

Study Completion Date

July 11, 2019

Conditions
Healthy
Interventions
DRUG

LC51-0255

0.25mg, 0.5mg, 1mg, 2mg, 4mg, 8mg

DRUG

Placebo

0.25mg, 0.5mg, 1mg, 2mg, 4mg, 8mg

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors

Lead Sponsor

LG Chem
All Listed Sponsors
lead

LG Chem

INDUSTRY

NCT03174613 - A Study To Evaluate The Safety, Pharmacokinetics/Pharmacodynamics (PK/PD) and Food Effect Of LC51-0255 | Biotech Hunter | Biotech Hunter